MORGAN STANLEY - Significant Ownership

Signature - Title: Chris O'Hara - Authorized Signatory
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by MORGAN STANLEY.

Significant Ownership of MORGAN STANLEY

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
KTCC	KEY TRONIC CORP	Common Stock	16%	$6.65M		1.73M		Morgan Stanley	Dec 31, 2024
WEA	WESTERN ASSET PREMIER BOND FUND	Common Shares of Beneficial Interest	13%	$17.2M		1.54M		Morgan Stanley	Dec 31, 2024
BMN	BlackRock 2037 Municipal Target Term Trust	Common Shares of Beneficial Interest	11.8%	$18.4M		727K		Morgan Stanley	Dec 31, 2024
ABUS	Arbutus Biopharma Corp	Common Shares	11.4%	$75.1M		21.5M		Morgan Stanley	Dec 31, 2024
AUR	Aurora Innovation, Inc.	Class A Common Stock	10.1%	$946M	$118M	141M	+14.3%	Morgan Stanley	Mar 31, 2025
LB	LandBridge Co LLC	Class A Shares	10%	$167M		2.33M		Morgan Stanley	Feb 28, 2025
GBAB	Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust	Common Shares of Beneficial Interest	9.6%	$37.1M		2.38M		Morgan Stanley	Dec 31, 2024
TYG	TORTOISE ENERGY INFRASTRUCTURE CORP	Common Stock	8.9%	$41.4M		961K		Morgan Stanley	Dec 31, 2024
OPP	RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.	Common Stock	8.7%	$17.2M		2M		Morgan Stanley	Dec 31, 2024
BGY	BlackRock Enhanced International Dividend Trust	Common Stock	8.6%	$46.2M		8.24M		Morgan Stanley	Dec 31, 2024
TSHA	Taysha Gene Therapies, Inc.	Common Stock	8.6%	$24.5M		17.6M		Morgan Stanley	Dec 31, 2024
NPCE	NeuroPace Inc	Common Stock	8.3%	$30.6M		2.49M		Morgan Stanley	Dec 31, 2024
NVST	Envista Holdings Corp	Common Stock	8.2%	$244M		14.1M		Morgan Stanley	Dec 31, 2024
AFRM	Affirm Holdings, Inc.	Class A Common Stock	8.1%	$999M		22.1M		Morgan Stanley	Dec 31, 2024
GLQ	Clough Global Equity Fund	Common Stock	7.9%	$9.31M		1.48M		Morgan Stanley	Dec 31, 2024
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	7.7%	$210M		9.59M		Morgan Stanley	Dec 31, 2024
IOT	Samsara Inc.	Class A Common Stock	7.6%	$786M		20.5M		Morgan Stanley	Dec 31, 2024
KRNT	Kornit Digital Ltd.	Ordinary Shares	7.5%	$67.9M		3.56M		Morgan Stanley	Dec 31, 2024
LUNG	Pulmonx Corp	Common Stock	7.5%	$20M		2.97M		Morgan Stanley	Dec 31, 2024
GUG	Guggenheim Active Allocation Fund	Common Shares	7.3%	$36.3M		2.41M		Morgan Stanley	Dec 31, 2024
NPCT	NUVEEN CORE PLUS IMPACT FUND	Common Shares of Beneficial Interest	7.3%	$22.6M		2.11M		Morgan Stanley	Dec 31, 2024
MUE	BLACKROCK MUNIHOLDINGS QUALITY FUND II, INC.	Common Shares	7.1%	$15.6M		1.56M		Morgan Stanley	Dec 31, 2024
GAXY	GALAXY NEXT GENERATION, INC.	Common Stock	6.9%	$48.4K		4.84M		Morgan Stanley	Dec 31, 2024
LSAK	LESAKA TECHNOLOGIES INC	Common Stock	6.6%	$24.6M		5.21M		Morgan Stanley	Dec 31, 2024
EMO	ClearBridge Energy Midstream Opportunity Fund Inc.	Common Stock	6.5%	$58.3M		1.18M		Morgan Stanley	Dec 31, 2024
STOK	Stoke Therapeutics, Inc.	Common Stock	6.5%	$22.8M		3.43M		Morgan Stanley	Dec 31, 2024
SNDX	Syndax Pharmaceuticals Inc	Common Stock	6.3%	$65.9M		5.36M		Morgan Stanley	Dec 31, 2024
PRAX	Praxis Precision Medicines, Inc.	Common Stock	6.2%	$43.8M		1.16M		Morgan Stanley	Dec 31, 2024
CYH	COMMUNITY HEALTH SYSTEMS INC	Common Stock	6.2%	$23.4M		8.65M		Morgan Stanley	Dec 31, 2024
BYON	BEYOND, INC.	Common Stock	6.1%	$16.2M		2.79M		Morgan Stanley	Dec 31, 2024
USPH	U S PHYSICAL THERAPY INC /NV	Common Stock	5.9%	$64.4M		890K		Morgan Stanley	Dec 31, 2024
COUR	Coursera, Inc.	Common Stock	5.9%	$62.2M		9.35M		Morgan Stanley	Dec 31, 2024
RDWR	RADWARE LTD	Ordinary Shares	5.9%	$53.6M		2.48M		Morgan Stanley	Dec 31, 2024
JKHY	JACK HENRY & ASSOCIATES INC	Common Stock	5.8%	$776M		4.25M		Morgan Stanley	Dec 31, 2024
TAL	TAL Education Group	Class A Common Shares	5.8%	$118M		8.91M		Morgan Stanley	Dec 31, 2024
HIO	WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC.	Common Shares of Beneficial Interest	5.8%	$21.8M		5.48M		Morgan Stanley	Dec 31, 2024
TBBB	BBB FOODS INC	Class A Common Shares	5.6%	$57.5M		2.18M		Morgan Stanley	Dec 31, 2024
RERE	ATRenew Inc.	Class A Ordinary Shares	5.6%	$14.4M		4.89M		Morgan Stanley	Dec 31, 2024
GLO	Clough Global Opportunities Fund	Common Shares of Beneficial Interest	5.6%	$11.8M		2.41M		Morgan Stanley	Dec 31, 2024
TPB	Turning Point Brands, Inc	Common Stock	5.4%	$56.6M		952K		Morgan Stanley	Dec 31, 2024
CCCC	C4 Therapeutics, Inc.	Common Stock	5.4%	$6.13M		3.83M		Morgan Stanley	Dec 31, 2024
AXGN	Axogen, Inc.	Common Stock	5.3%	$43.1M		2.33M		Morgan Stanley	Dec 31, 2024
EMD	WESTERN ASSET EMERGING MARKETS DEBT FUND INC.	Common Stock	5.3%	$30.7M		3.1M		Morgan Stanley	Dec 31, 2024
EAD	ALLSPRING INCOME OPPORTUNITIES FUND	Common Shares	5.1%	$20.7M		3.03M		Morgan Stanley	Dec 31, 2024
	Theratechnologies Inc.	Common Shares	5%			2.31M		Morgan Stanley	Dec 31, 2024
JRI	Nuveen Real Asset Income & Growth Fund	Common Stock	4.9%	$17.4M		1.34M		Morgan Stanley	Dec 31, 2024
DASH	DoorDash, Inc.	Class A Common Stock	4.8%	$3.43B		18.8M		Morgan Stanley	Dec 31, 2024
SDHY	PGIM Short Duration High Yield Opportunities Fund	Common Shares	4.7%	$19M		1.15M		Morgan Stanley	Dec 31, 2024
ASGI	abrdn Global Infrastructure Income Fund	Common Shares of Beneficial Interest	4.5%	$24M		1.31M		Morgan Stanley	Dec 31, 2024
SPHR	Sphere Entertainment Co.	Class A Common Stock	4.4%	$41.6M		1.27M		Morgan Stanley	Dec 31, 2024

Previous1 2Next

Showing 1 to 50 of 72 entries

Schedules 13D/G Reported by MORGAN STANLEY:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
Loading...

PreviousNext

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.